Skip to Content


MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

International Parkinson and Movement Disorder Society
Main Content

        VOLUME 28, ISSUE 1 • March, 2024.  Full issue »

International conference focuses on innovations in Movement Disorders 

The 4th International Conference of Korean Movement Disorder Society (IC-KMDS) was in Busan, Korea on December 1-2, 2023. IC-KMDS is the largest biennial international conference of movement disorders in South Korea, which is hosted and organized by the Korean Movement Disorder Society (KMDS). After the long endurance of COVID-19, more than 500 researchers from 23 countries attended this conference in person, and more than 200 posters were displayed.

Renowned international movement disorder specialists joined the conference as faculty, including Prof. Ai Huey Tan (Malaysia), Prof. Tiago F. Outeiro (Germany), Prof. Pramod Pal (India), Prof. Hrishikesh Kumar (India), Prof. Antonio Martin-Bastida (Spain), Prof. Thilo van Eimeren (Germany), Prof. Nobutaka Hattori (Japan), Prof. Simon Lewis (Australia), Prof. Laurie King (USA), Prof. Roongroj Bhidayasiri (Thailand), Prof. Eng-King Tan (Singapore), Prof. Elizabeth A. Coon (USA), Prof. Janis M. Miyasaki (Canada), Prof. Andres Lozano (Canada), Prof. Marina Picillo (Italy), Prof. Arlene R. Ng (Philippines), Prof. Ruey-Meei Wu (Taiwan), Prof. Raymond Rosales (Philippines), Prof. Chin-Hsien Lin (Taiwan), Prof. Shen-Yang Lim (Malaysia), and Prof. Victor Fung (Australia).

On the second day, the plenaries highlighted updates in treatment from basic science to non-pharmacological management, treatments for non-motor symptoms in Parkinson’s disease, and updates in neuroimaging studies. Prodromal stages including idiopathic rapid eye movement sleep behavior disorder and pure autonomic failure, ws well as debates in propagation of Lewy-body disease in neuropathologic perspective, were discussed in depth.

This IC-KMDS focused on recent advancements and innovative methods in the diagnosis and treatment of movement disorders. Topics of plenary sessions included therapeutic innovation in cellular reprogramming, gene therapy, and microbiome-based therapeutics. The program also reviewed alpha-synuclein related pathophysiology and imaging, as well as recent developments in non-invasive therapy, such as repetitive transcranial magnetic stimulation, peripheral nerve stimulation, and transcranial direct current stimulation. Growing interest in biomarkers, especially seed amplification assay, and the future of gait analysis were also discussed.

In addition, an oral presentation session featuring selected abstracts of particular interest provided opportunities for promising researchers to share their work and promote communication. Under-recognized issues in movement disorders, including caregiver management and advanced-stage care, were also discussed.

The conference also explored emerging needs to broaden our understanding for rapidly changing digital technologies. Dr. Jaeyeon Jung, the vice president for service R&D at Mobile Communications Business in Samsung Electronics, was invited to present about the current status of smart home technology and discuss new research possibilities. 

This IC-KMDS was a success in the beautiful harbor city Busan, and was an opportunity for international researchers and attendees to enjoy and expand relationships through academic conferences and network meetings. We look forward to the next IC-KMDS, which will be held again in two years, 2025.


Read more Moving Along:

Full issue    Archives

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including and This cookie policy only covers the primary and domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice